微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Fulcrum Therapeutics (NASDAQ:FULC) +125%
Exagen (NASDAQ:XGN) +24%
Myomo (NYSE:MYO) +16%
IMV (NASDAQ:IMV) +8%
Allied Healthcare Products (NASDAQ:AHPI) +6%
Losers:...查看全文
$Exagen(XGN)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-21-091233 Act: 33 Size: 614 KB 网页链接
$Exagen(XGN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001274737-21-000021 Act: 34 Size: 438 KB 网页链接
$Exagen(XGN)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0001274737-21-000017 Act: 34 Size: 282 KB 网页链接
$Exagen(XGN)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-21-089541 Act: 33 Size: 613 KB 网页链接
$Exagen(XGN)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001274737-21-000015 Act: 34 Size: 9 MB 网页链接
$Exagen(XGN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001274737-21-000014 Act: 34 Size: 155 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-21-000008 Size: 7 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-21-000009 Size: 7 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-21-000010 Size: 7 KB 网页链接
$Exagen(XGN)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0001193125-21-054718 Act: 34 Size: 105 KB 网页链接